Terrance McGuire, Director at Cyclerion Therapeutics, Inc. (CYCN), bought 626,117 shares at $16.00 ($10.0M) on 2019-04-08, disclosed to the SEC on 2019-04-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.00 | 21,635 | $346K | 3.5% |
| 2 | $16.00 | 604,482 | $9.7M | 96.5% |
| Total | $16.00 avg | 626,117 | $10.0M | 100% |
| Filing → |
| IVVD | SELL | 2024-12-26 | $215K | — | Filing → |
| IVVD | SELL | 2024-12-19 | $213K | — | Filing → |
| IVVD | SELL | 2024-12-16 | $103K | — | Filing → |